Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sihui Luo

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Signal Transduction and Targeted Therapy|July 13, 2021
The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunctionSuowen Xu, Yujie Liu, Yu Ding, et al.
Diabetes/Metabolism Research and Reviews|November 15, 2024
Performance of Continuous Glucose Monitoring System Among Patients With Acute Ischaemic Stroke Treated With Mechanical ThrombectomyJie Shi, Jiahao Weng, Yu Ding, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2021
Achieving the HbA1c Target Requires Longer Time in Range in Pregnant Women With Type 1 DiabetesPing Ling, Daizhi Yang, Nan Gu, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|November 22, 2021
A global assessment of the impact of school closure in reducing COVID-19 spreadJoseph T Wu, Shujiang Mei, Sihui Luo, et al.
Therapeutic Advances in Endocrinology and Metabolism|June 20, 2020
Impacts of glycemic variability on the relationship between glucose management indicator from iPro<sup>™</sup>2 and laboratory hemoglobin A1c in adult patients with type 1 diabetes mellitusHongxia Liu, Daizhi Yang, Hongrong Deng, et al.
Diabetes/Metabolism Research and Reviews|May 29, 2020
Adult-onset type 1 diabetic patients with less severe clinical manifestation have less risk DR-DQ genotypes than childhood-onset patientsWenqian Ren, Daizhi Yang, Ziyu Jiang, et al.
Diabetologia|May 23, 2021
HLA class I genes modulate disease risk and age at onset together with DR-DQ in Chinese patients with insulin-requiring type 1 diabetesZiyu Jiang, Wenqian Ren, Hua Liang, et al.
Pharmacological Reviews|June 5, 2021
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to PharmacotherapiesSuowen Xu, Iqra Ilyas, Peter J Little, et al.
Science Bulletin|April 17, 2026
Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axisMengya Geng, Fanzheng Meng, Hairui Li, et al.
Eclinicalmedicine|February 22, 2021
Clinical outcomes of different therapeutic options for COVID-19 in two Chinese case cohorts: A propensity-score analysisCarlos K H Wong, Eric Y F Wan, Sihui Luo, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Signal Transduction and Targeted Therapy|July 13, 2021
The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunctionSuowen Xu, Yujie Liu, Yu Ding, et al.
Diabetes/Metabolism Research and Reviews|November 15, 2024
Performance of Continuous Glucose Monitoring System Among Patients With Acute Ischaemic Stroke Treated With Mechanical ThrombectomyJie Shi, Jiahao Weng, Yu Ding, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2021
Achieving the HbA1c Target Requires Longer Time in Range in Pregnant Women With Type 1 DiabetesPing Ling, Daizhi Yang, Nan Gu, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|November 22, 2021
A global assessment of the impact of school closure in reducing COVID-19 spreadJoseph T Wu, Shujiang Mei, Sihui Luo, et al.
Therapeutic Advances in Endocrinology and Metabolism|June 20, 2020
Impacts of glycemic variability on the relationship between glucose management indicator from iPro<sup>™</sup>2 and laboratory hemoglobin A1c in adult patients with type 1 diabetes mellitusHongxia Liu, Daizhi Yang, Hongrong Deng, et al.
Diabetes/Metabolism Research and Reviews|May 29, 2020
Adult-onset type 1 diabetic patients with less severe clinical manifestation have less risk DR-DQ genotypes than childhood-onset patientsWenqian Ren, Daizhi Yang, Ziyu Jiang, et al.
Diabetologia|May 23, 2021
HLA class I genes modulate disease risk and age at onset together with DR-DQ in Chinese patients with insulin-requiring type 1 diabetesZiyu Jiang, Wenqian Ren, Hua Liang, et al.
Pharmacological Reviews|June 5, 2021
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to PharmacotherapiesSuowen Xu, Iqra Ilyas, Peter J Little, et al.
Science Bulletin|April 17, 2026
Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axisMengya Geng, Fanzheng Meng, Hairui Li, et al.
Eclinicalmedicine|February 22, 2021
Clinical outcomes of different therapeutic options for COVID-19 in two Chinese case cohorts: A propensity-score analysisCarlos K H Wong, Eric Y F Wan, Sihui Luo, et al.
Pageof 9